Janus Henderson Group PLC Purchases 139,214 Shares of HCP, Inc. (HCP)
Janus Henderson Group PLC boosted its position in HCP, Inc. (NYSE:HCP) by 16.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,008,528 shares of the real estate investment trust’s stock after purchasing an additional 139,214 shares during the period. Janus Henderson Group PLC’s holdings in HCP were worth $26,548,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of HCP. Mount Yale Investment Advisors LLC bought a new stake in shares of HCP in the 2nd quarter valued at about $104,000. Piedmont Investment Advisors LLC bought a new stake in shares of HCP in the 2nd quarter valued at about $142,000. Peoples Financial Services CORP. grew its position in shares of HCP by 87.7% in the 3rd quarter. Peoples Financial Services CORP. now owns 6,100 shares of the real estate investment trust’s stock valued at $161,000 after buying an additional 2,850 shares during the last quarter. Wetherby Asset Management Inc. bought a new stake in shares of HCP in the 3rd quarter valued at about $200,000. Finally, Lourd Capital LLC bought a new stake in shares of HCP in the 3rd quarter valued at about $211,000. 90.00% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts have commented on HCP shares. Bank of America upped their price target on HCP from $27.50 to $28.00 and gave the company a “buy” rating in a research report on Monday, September 17th. JPMorgan Chase & Co. lowered HCP from an “overweight” rating to a “neutral” rating in a research report on Friday, October 5th. Cantor Fitzgerald upgraded HCP from a “neutral” rating to an “overweight” rating and upped their price target for the company from $28.00 to $29.00 in a research report on Thursday, September 27th. Zacks Investment Research reiterated a “sell” rating on shares of HCP in a research report on Tuesday, November 13th. Finally, Royal Bank of Canada upgraded HCP from a “sector perform” rating to an “outperform” rating in a research report on Friday, November 2nd. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $26.75.
HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.10. The business had revenue of $456.00 million for the quarter, compared to analyst estimates of $456.59 million. HCP had a return on equity of 3.06% and a net margin of 9.16%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.48 earnings per share. Equities research analysts expect that HCP, Inc. will post 1.82 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 20th. Stockholders of record on Monday, November 5th were paid a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 5.09%. The ex-dividend date of this dividend was Friday, November 2nd. HCP’s dividend payout ratio (DPR) is presently 75.90%.
ILLEGAL ACTIVITY WARNING: This article was originally published by Watch List News and is the property of of Watch List News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/janus-henderson-group-plc-purchases-139214-shares-of-hcp-inc-hcp/2664318.html.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Article: Diversification Important in Investing
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.